Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with...

Abstract

The data from this follow-up study continue to support the utility of enhanced RT-PCR as an early staging modality for radical prostatectomy candidates.

Keywords

MedicineProstatectomyProstate cancerProstate-specific antigenProstateStage (stratigraphy)UrologyCancerRectal examinationPathologyBiochemical recurrenceInternal medicine

Affiliated Institutions

Columbia University US

Related Publications

Community psycho-behavioural surveillance and related impact on outbreak control in Hong Kong and Singapore during the SARS epidemic.

GM Leung , Stella R. Quah , LM Ho +4 more

1. The promotion of personal protective health practices must take into account background perceptions of risk and psychological responses in the community-at-large. 2. Populati...

2009 PubMed 36 citations

2018 New England Journal of Medicine 5890 citations

Publication Info

Year: 1995
Type: article
Volume: 75
Issue: 7
Pages: 1642-1648
Citations: 115
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

115

OpenAlex

Cite This

APA Style

                            
                                
                                    A E Katz, 
                                
                                    Glen M. de Vries, 
                                
                                    Melissa D. Begg
                                
                                et al.
                            
                            (1995). 
                            Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. 
                            Cancer
                            , 75
                            (7)
                            , 1642-1648.
                            https://doi.org/10.1002/1097-0142(19950401)75:7<1642::aid-cncr2820750714>3.0.co;2-1
                        

Identifiers

DOI: 10.1002/1097-0142(19950401)75:7<1642::aid-cncr2820750714>3.0.co;2-1